CHRISTY SHAFFER

Christy Shaffer stands as a distinguished General Partner at Hatteras Venture Partners, a leading venture capital firm dedicated to fostering innovation within the life sciences sector. With a profound understanding of drug development and commercialization, Shaffer plays a pivotal role in identifying, funding, and nurturing groundbreaking companies that aim to address significant medical needs.

Her investment focus at Hatteras Venture Partners is sharply defined, primarily targeting early-stage companies across various segments of the life sciences. This includes biotechnology, pharmaceuticals, medical devices, and diagnostics. Shaffer's expertise allows her to discern the potential in novel therapeutic platforms, innovative medical technologies, and disruptive diagnostic tools, guiding these ventures from their nascent stages towards clinical and commercial success. She is particularly adept at evaluating scientific merit, market potential, and the operational capabilities of founding teams.

Shaffer's career background is exceptionally rich, providing her with an invaluable perspective as an investor. Prior to joining Hatteras Venture Partners, she held significant leadership positions that honed her operational acumen. Notably, she served as President and CEO of Inspire Pharmaceuticals, a company she successfully led through its growth phase, culminating in its acquisition by Merck. Her earlier career also includes key roles at Glaxo Wellcome (now part of GSK), where she gained extensive experience in drug development and commercial strategy across multiple therapeutic areas. Holding a Doctor of Pharmacy (PharmD) degree, Shaffer combines deep scientific knowledge with practical business leadership, a rare and powerful combination in the venture capital landscape.

At Hatteras Venture Partners, Christy Shaffer's role extends beyond capital allocation. She actively engages with portfolio companies, offering strategic guidance, operational insights, and mentorship to management teams. Her experience in scaling biotech companies and navigating complex regulatory pathways is instrumental in helping entrepreneurs overcome challenges and accelerate their development timelines. While specific public notable investments are often attributed to the firm, Shaffer's influence is evident in the strategic direction and growth of numerous companies within the Hatteras portfolio, leveraging her prior successes and deep industry network to drive value.

Christy Shaffer's commitment to advancing healthcare through strategic investment and hands-on support makes her a formidable force in the life sciences venture capital community. Her blend of scientific rigor, operational leadership, and investment acumen positions her as a key partner for entrepreneurs striving to bring life-changing innovations to patients worldwide.